General anesthesia is a reversible, drug-induced behavioral state comprised of unconsciousness, amnesia, analgesia and immobility with stability and control of vital physiological systems. This fundamental tool of modern medicine is crucial for allowing thousands of patients daily to safely undergo most surgical and many non-surgical procedures. Today this state is induced and maintained by administering multiple drugs that act at multiple sites in the brain and central nervous system. Emergence from general anesthesia is a passive process whereby anesthetic drugs are merely discontinued at the end of surgery and no drugs are administered to actively reverse their effects. Allowing multiple drugs to act at multiple sites without specific mechanisms to terminate their effects most likely explains a significant component of anesthesia-related morbidity;drug side effects (nausea, hypotension, respiratory depression, hypothermia) are due to actions at sites other than their intended targets whereas persistent effects (delirium, cognitive dysfunction) are due to actions at intended targets for periods longer than desired. Hence, general anesthesia, as presently produced, is highly non-specific and inefficient. Despite the central role of anesthesiology in modern healthcare, research in this field is overly focused on deciphering the anesthetic and toxic mechanisms of current drugs with little to no attention being paid to developing new approaches. The paradigm-shifting question whose answer will revolutionize anesthesiology is not, """"""""how do current anesthetics work?"""""""", but rather, """"""""how should the state of general anesthesia be designed?"""""""" We hypothesize that the answer is by developing strategies to control directly the brain's natural inhibitory pathways and arousal centers. We propose to redesign general anesthesia by combining optogenetic, electrical and pharmacological manipulations in rodent models to create this behavioral state through precisely timed control of the brain's natural inhibitory pathways and its arousal centers. If successful this research will provide a new fundamental understanding of brain arousal control, and eventually, new anesthesiology practices including: neurophysiologically-designed approaches to creating general anesthesia;reduction in morbidity;improved brain function monitoring;safer anesthesia care by non-anesthesiologists;and possibly novel therapies for arousal disorders such as depression, insomnia, pain and coma.

Public Health Relevance

In the United States, more than 100,000 patients receive general anesthesia daily to safely undergo most surgical and many non-surgical procedures Use of anesthetic drugs by non-anesthesiologists in intensive care units and outpatient settings continues to grow. At the same time, anesthesia-related morbidity, including intra-operative awareness, altered neurological development and delirium in children and cognitive dysfunction in the elderly remains a significant problem. Despite the central role of anesthesiology in modern healthcare, research in this field is stagnant;overly focused on deciphering the anesthetic and toxic mechanisms of current drugs with no attention to developing new approaches. We propose to redesign general anesthesia by combining optogenetic, electrical and pharmacological manipulations in rodent models to create this behavioral state through precisely timed control of the brain's natural inhibitory pathways and its arousal centers. If successful this research will provide a new fundamental understanding of brain arousal control, and eventually, new anesthesiology practices including: neurophysiologically-designed approaches to creating general anesthesia;reduction in morbidity;improved brain function monitoring;safer anesthesia care by non- anesthesiologists;and possibly novel therapies for arousal disorders such as depression, insomnia, pain and coma.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM104948-01
Application #
8412622
Study Section
Special Emphasis Panel (ZRG1-BCMB-A (51))
Program Officer
Cole, Alison E
Project Start
2012-09-25
Project End
2017-08-31
Budget Start
2012-09-25
Budget End
2013-08-31
Support Year
1
Fiscal Year
2012
Total Cost
$1,120,750
Indirect Cost
$261,901
Name
Massachusetts Institute of Technology
Department
Other Basic Sciences
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Nagasaka, Yasuko; Wepler, Martin; Thoonen, Robrecht et al. (2017) Sensitivity to Sevoflurane anesthesia is decreased in mice with a congenital deletion of Guanylyl Cyclase-1 alpha. BMC Anesthesiol 17:76
Piatkevich, Kiryl D; Suk, Ho-Jun; Kodandaramaiah, Suhasa B et al. (2017) Near-Infrared Fluorescent Proteins Engineered from Bacterial Phytochromes in Neuroimaging. Biophys J 113:2299-2309
Miran, Sina; Purdon, Patrick L; Brown, Emery N et al. (2017) Robust Estimation of Sparse Narrowband Spectra from Neuronal Spiking Data. IEEE Trans Biomed Eng 64:2462-2474
Zhao, Yongxin; Bucur, Octavian; Irshad, Humayun et al. (2017) Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy. Nat Biotechnol 35:757-764
Guidera, Jennifer A; Taylor, Norman E; Lee, Justin T et al. (2017) Sevoflurane Induces Coherent Slow-Delta Oscillations in Rats. Front Neural Circuits 11:36
Song, Andrew H; Kucyi, Aaron; Napadow, Vitaly et al. (2017) Pharmacological Modulation of Noradrenergic Arousal Circuitry Disrupts Functional Connectivity of the Locus Ceruleus in Humans. J Neurosci 37:6938-6945
Chen, Zhe; Wilson, Matthew A (2017) Deciphering Neural Codes of Memory during Sleep. Trends Neurosci 40:260-275
Flores, Francisco J; Hartnack, Katharine E; Fath, Amanda B et al. (2017) Thalamocortical synchronization during induction and emergence from propofol-induced unconsciousness. Proc Natl Acad Sci U S A 114:E6660-E6668
Rowlands, Christopher J; Park, Demian; Bruns, Oliver T et al. (2017) Wide-field three-photon excitation in biological samples. Light Sci Appl 6:e16255
Hashmi, Javeria A; Loggia, Marco L; Khan, Sheraz et al. (2017) Dexmedetomidine Disrupts the Local and Global Efficiencies of Large-scale Brain Networks. Anesthesiology 126:419-430

Showing the most recent 10 out of 62 publications